UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
SNUH opens new Covid-19 treatment center in 2 days
by Shim Hyun-tai
2020-08-27 18:06
Genexine's cytokine drug effective on severe Covid-19 patients
by Shim Hyun-tai
2020-08-27 18:05
Korea publishes guidelines for digital therapeutics
by Kim Yun-mi
2020-08-27 18:05
Drugmakers to sue government for limiting choline alfoscerate benefit
by Kim Yun-mi
2020-08-27 14:26
Stocks of 3 Covid-19 vaccine developers spike
by Kim Chan-hyuk
2020-08-27 14:07
라인
New virus cases reach six-month high; tightest restrictions imminent
by Shim Hyun-tai
2020-08-27 13:24
Helixmith’s antibody therapy shows efficacy in immunoglobulin kidney disease
by Shim Hyun-tai
2020-08-26 17:47
Celltrion to begin P1 trial of antibody-drug on mild Covid-19 patients
by Shim Hyun-tai
2020-08-26 17:17
‘Stringent social distancing can calm Covid-19 in early September’
by Song Soo-youn
2020-08-26 16:25
Why medical school students give up pursuing public health jobs
by Song Soo-youn
2020-08-26 16:21
라인
HK inno.N, T&R Biofab to develop skin therapy using 3D tech
by Shim Hyun-tai
2020-08-26 16:19
Virus cases rebound above 300, pushing nation closer to tightest restrictions
by Shim Hyun-tai
2020-08-26 13:35
Novartis fails trial on skin cancer drug candidate spartalizumab
by Kim Yun-mi
2020-08-26 11:11
CrystalGenomics’ anticancer candidate has FDA’s orphan drug status
by Shim Hyun-tai
2020-08-25 17:07
[Column] How ongoing doctors’ strike is different from 20 years ago
by Park Jae-young Executive editor
2020-08-25 17:07
라인
PharmAbcine, Samsung Biologics sign CDMO deal for antibody candidate
by Shim Hyun-tai
2020-08-25 16:57
Huons' eye drop wins Saudi’s regulatory nod
by Shim Hyun-tai
2020-08-25 14:50
New virus cases below 300 for 2nd day but spreads continue
by Shim Hyun-tai
2020-08-25 11:51
Drugmakers in active open innovation with startups
by Kim Chan-hyuk
2020-08-25 11:51
HK inno.N publishes P3 trial results of drug on gastric ulcers
by Shim Hyun-tai
2020-08-24 18:02
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top